Epidemiology, antimicrobial resistance (AMR), virulence, and control of Klebsiella pneumoniae, a bacterial pathogen with high clinical significance
摘要截稿:
全文截稿: 2025-08-31
影响因子: 3.97
期刊难度:
CCF分类: 无
中科院JCR分区:
• 大类 : 生物学 - 2区
• 小类 : 微生物学 - 3区
Overview
The Special Issue accepts research on epidemiology, antimicrobial resistance (AMR), virulence, and control of Klebsiella pneumoniae.
Guest editors:
Sheng Chen, The Hong Kong Polytechnic University, Hung Hom, Hong Kong
Rong Zhang, Hospital of Zhejiang University, Zhejiang, China
Ruichao Li, Yangzhou University, Yangzhou, China
Special issue information:
Klebsiella pneumoniae is a Gram-negative bacterium belonging to the Enterobacteriaceae family. It is a ubiquitous organism found in various environmental niches, including soil, water, and plants, as well as in the gastrointestinal tracts of humans and animals. While K. pneumoniae is a commensal bacterium in healthy individuals, it can also act as a formidable opportunistic pathogen, causing a wide range of infections with significant clinical implications. First identified by Carl Friedländer in 1882, K. pneumoniae was initially recognized as a cause of pneumonia, particularly in individuals with impaired host defence mechanisms. It has been shown to cause a wide range of infections, including pneumonia, urinary tract infections (UTIs), bloodstream infections (BSIs), and surgical site infections (SSIs) and is frequently implicated nosocomial infections, particularly in intensive care units (ICUs) and long-term care facilities. Owing to its rapid evolution, it has evolved into several clinically significant pathogens such as carbapenem-resistant K. pneumoniae (CRKP), hypervirulent K. pneumoniae (HvKP) and carbapenem-resistant and hypervirulent K. pneumoniae (CR-HvKP). It therefore has become a major public health concern worldwide.In recent years, research on K. pneumoniae have increased dramatically, which provided novel insights into the better understanding of this important bacterial pathogen. We therefore design this special issue to collect advanced research in various aspects of this important bacteria including epidemiology, the mechanisms underlying its antimicrobial resistance and virulence, as well as the strategies employed for the control and treatment of clinical K. pneumoniae.
Manuscript submission information:
Submission site: https://www.editorialmanager.com/MICRES/default.aspx
Article Type: VSI: Klebsiella pneumoniae
Submission due date: 31 March 2025